secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001193125-23-150518
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Carl Morris resigns as CSO Neuromuscular; Jennifer Marlowe to become CSO
------------------------------------------------------------------------

- Carl Morris resigns as Chief Scientific Officer, Neuromuscular, effective July 14, 2023.
- Jennifer Marlowe, current CSO Friedreich's Ataxia and Cardiac Pipeline, will assume role of CSO.
- Morris receives severance: 1 year base salary, COBRA for 12 months, $172,200 lump sum (100% of 2023 target bonus).
- Morris to enter consulting agreement through March 31, 2024; time-based equity awards continue vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312523150518/0001193125-23-150518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312523150518/d696236d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-150518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer